King Pharmaceuticals, is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals.

Property Value
dbo:abstract
  • King Pharmaceuticals war ein im S&P 500 gelistetes Pharmazieunternehmen aus den Vereinigten Staaten. Es wurde 2010 von Pfizer übernommen. Der Hauptsitz des Unternehmens befand sich in Bristol, Tennessee. King Pharmaceuticals stellte eine große Anzahl von verschiedenen Medikamenten her, insbesondere Altace für Herzinfarktvorsorge, Levoxyl für Hyphothyroidism, Sonata, ein Schlafstörungsmedikament und Skelaxin, ein Muskelentspannungsmedikament. Monarch Pharmaceuticals, Inc. war ein Tochterunternehmen. (de)
  • King Pharmaceuticals, is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals. King Pharmaceuticals, Inc. was incorporated in the State of Tennessee in 1993. According to the King Pharmaceutcals, Inc. Form 10-K for the year ended December 31, 2007 filed with the U.S. Securities and Exchange Commission, the wholly owned subsidiaries of King Pharmaceuticals, Inc. are Monarch Pharmaceuticals, Inc.; King Pharmaceuticals Research and Development, Inc.; Meridian Medical Technologies, Inc.; Parkedale Pharmaceuticals, Inc.; King Pharmaceuticals Canada Inc.; and Monarch Pharmaceuticals Ireland Limited. (en)
dbo:industry
dbo:location
dbo:netIncome
  • 9.2E7
dbo:numberOfEmployees
  • 3381 (xsd:integer)
dbo:operatingIncome
  • 2.36E8
dbo:product
dbo:revenue
  • 1.7E9
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 2440535 (xsd:integer)
dbo:wikiPageRevisionID
  • 736250649 (xsd:integer)
dbp:keyPeople
  • Brian Markison, CEO
  • Eric J. Bruce, CTO
  • Joseph Squicciarino, CFO
dbp:logo
dbp:wordnet_type
dct:subject
rdf:type
rdfs:comment
  • King Pharmaceuticals war ein im S&P 500 gelistetes Pharmazieunternehmen aus den Vereinigten Staaten. Es wurde 2010 von Pfizer übernommen. Der Hauptsitz des Unternehmens befand sich in Bristol, Tennessee. King Pharmaceuticals stellte eine große Anzahl von verschiedenen Medikamenten her, insbesondere Altace für Herzinfarktvorsorge, Levoxyl für Hyphothyroidism, Sonata, ein Schlafstörungsmedikament und Skelaxin, ein Muskelentspannungsmedikament. Monarch Pharmaceuticals, Inc. war ein Tochterunternehmen. (de)
  • King Pharmaceuticals, is a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company. On October 12, 2010, King was acquired by Pfizer for $14.25 per share. King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals. (en)
rdfs:label
  • King Pharmaceuticals (de)
  • King Pharmaceuticals (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • King Pharmaceuticals (en)
is dbo:wikiPageDisambiguates of
is dbo:wikiPageRedirects of
is foaf:primaryTopic of